1. Home
  2. AMP vs ALC Comparison

AMP vs ALC Comparison

Compare AMP & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMP
  • ALC
  • Stock Information
  • Founded
  • AMP 1894
  • ALC 1945
  • Country
  • AMP United States
  • ALC Switzerland
  • Employees
  • AMP N/A
  • ALC N/A
  • Industry
  • AMP Investment Managers
  • ALC Ophthalmic Goods
  • Sector
  • AMP Finance
  • ALC Health Care
  • Exchange
  • AMP Nasdaq
  • ALC Nasdaq
  • Market Cap
  • AMP 48.6B
  • ALC 43.2B
  • IPO Year
  • AMP 2005
  • ALC N/A
  • Fundamental
  • Price
  • AMP $518.23
  • ALC $87.55
  • Analyst Decision
  • AMP Hold
  • ALC Buy
  • Analyst Count
  • AMP 8
  • ALC 10
  • Target Price
  • AMP $548.67
  • ALC $106.88
  • AVG Volume (30 Days)
  • AMP 421.5K
  • ALC 1.5M
  • Earning Date
  • AMP 07-24-2025
  • ALC 08-19-2025
  • Dividend Yield
  • AMP 1.24%
  • ALC 0.25%
  • EPS Growth
  • AMP 9.94
  • ALC 6.66
  • EPS
  • AMP 32.06
  • ALC 2.25
  • Revenue
  • AMP $18,180,000,000.00
  • ALC $9,925,000,000.00
  • Revenue This Year
  • AMP N/A
  • ALC $6.75
  • Revenue Next Year
  • AMP $4.82
  • ALC $7.60
  • P/E Ratio
  • AMP $16.16
  • ALC $39.13
  • Revenue Growth
  • AMP 7.19
  • ALC 3.80
  • 52 Week Low
  • AMP $385.74
  • ALC $80.48
  • 52 Week High
  • AMP $582.05
  • ALC $101.10
  • Technical
  • Relative Strength Index (RSI)
  • AMP 43.98
  • ALC 45.99
  • Support Level
  • AMP $500.91
  • ALC $89.94
  • Resistance Level
  • AMP $526.35
  • ALC $91.61
  • Average True Range (ATR)
  • AMP 10.67
  • ALC 1.42
  • MACD
  • AMP -2.86
  • ALC 0.06
  • Stochastic Oscillator
  • AMP 39.29
  • ALC 28.88

About AMP Ameriprise Financial Inc.

Ameriprise Financial is a major player in the US market for asset and wealth management, with around $1.5 trillion in total assets under management and administration at the end of 2024. With about 10,500 advisors, Ameriprise has one of the largest branded advisor networks in the industry. About 80% of the company's revenue comes from its asset and wealth management segments. Ameriprise has reduced its exposure to insurance with the sale of its auto and home insurance business in 2019 and discontinuing the sale of proprietary fixed annuities in 2020.

About ALC Alcon Inc.

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

Share on Social Networks: